Vardenafil hydrochloride and Visual field defect - a phase IV clinical study of FDA data
Visual field defect is reported only by a few people who take Vardenafil Hydrochloride.
The phase IV clinical study analyzes which people take Vardenafil hydrochloride and have Visual field defect. It is created by eHealthMe based on reports of 227 people who have side effects while taking Vardenafil hydrochloride from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
227 people reported to have side effects when taking Vardenafil hydrochloride.
Among them, 2 people (0.88%) have Visual field defect.
What is Vardenafil hydrochloride?
Vardenafil hydrochloride has active ingredients of vardenafil hydrochloride. It is often used in erection problems. eHealthMe is studying from 240 Vardenafil hydrochloride users for its effectiveness, alternative drugs and more.
What is Visual field defect?
Visual field defect is found to be associated with 1,399 drugs and 974 conditions by eHealthMe.
Number of Vardenafil hydrochloride and Visual field defect reports submitted per year:
Gender of people who have Visual field defect when taking Vardenafil hydrochloride *:
- female: 0.0 %
- male: 100 %
Age of people who have Visual field defect when taking Vardenafil hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common side effects people have besides Visual field defect *:
- Optic Nerve Injury: 2 people, 100.00%
- Optic Ischaemic Neuropathy (optic nerve damage due to lack of blood supply): 2 people, 100.00%
- Blindness Unilateral: 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Vardenafil hydrochloride and have Visual field defect?Check whether Visual field defect is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Visual field defect and when was it recovered:
Expand to all the drugs that have ingredients of vardenafil hydrochloride:
Alternative drugs to, pros and cons of Vardenafil hydrochloride:
- Vardenafil hydrochloride (240 reports)
Visual field defect treatments and more:
- Visual field defect (8,169 reports)
COVID vaccines that are related to Visual field defect:
- Visual field defect in Moderna COVID Vaccine
- Visual field defect in Pfizer BioNTech Covid Vaccine
- Visual field defect in Johnson and Johnson Covid Vaccine
Common drugs associated with Visual field defect:
- Aspirin: 407 reports
- Prednisone: 314 reports
- Lyrica: 265 reports
- Viagra: 260 reports
- Lipitor: 248 reports
- Lisinopril: 244 reports
- Methotrexate: 243 reports
- Gilenya: 242 reports
- Humira: 217 reports
- Sabril: 184 reports
All the drugs that are associated with Visual field defect:
- Visual field defect (1,399 drugs)
Common conditions associated with Visual field defect:
- Multiple sclerosis: 593 reports
- High blood pressure: 362 reports
- Depression: 283 reports
- Rheumatoid arthritis: 224 reports
- Glaucoma: 223 reports
- Erection problems: 215 reports
- High blood cholesterol: 195 reports
All the conditions that are associated with Visual field defect:
- Visual field defect (974 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on vardenafil hydrochloride (the active ingredients of Vardenafil hydrochloride) and Vardenafil hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Boswellia vs. Enbrel - 2 seconds ago
- Rufinamide and Head Injury - 14 seconds ago
- Nitrous Oxide W/ Oxygen vs. Baclofen - 18 seconds ago
- Cimzia and Arrhythmias - 19 seconds ago
- Humulin N and Irritability - 20 seconds ago
- Cortef and Toviaz drug interaction - 20 seconds ago
- Simponi and Breast Pain - 24 seconds ago
- Lotensin Hct vs. Lopressor Hct - 25 seconds ago
- Rebetol and Monocyte Count Decreased - 26 seconds ago
- Phentermine Resin 30 vs. Wellbutrin - 29 seconds ago